ES2078324T3 - Pteridina-4 (3h)-onas, procedimientos de preparacion y medicamentos que los contienen. - Google Patents

Pteridina-4 (3h)-onas, procedimientos de preparacion y medicamentos que los contienen.

Info

Publication number
ES2078324T3
ES2078324T3 ES90400827T ES90400827T ES2078324T3 ES 2078324 T3 ES2078324 T3 ES 2078324T3 ES 90400827 T ES90400827 T ES 90400827T ES 90400827 T ES90400827 T ES 90400827T ES 2078324 T3 ES2078324 T3 ES 2078324T3
Authority
ES
Spain
Prior art keywords
onas
atom
pteridine
group
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90400827T
Other languages
English (en)
Inventor
Gerard Ferrand
Herve Dumas
Jean-Claude Depin
Yvette Quentin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sante SAS
Original Assignee
LIPHA SAS
LIPHA Liyonnaise Industrielle Pharmaceutique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LIPHA SAS, LIPHA Liyonnaise Industrielle Pharmaceutique filed Critical LIPHA SAS
Application granted granted Critical
Publication of ES2078324T3 publication Critical patent/ES2078324T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A PTERIDIN-4 (3H)-ONAS REPRESENTADAS POR LA FORMULA; (FIG. A), EN LA QUE X ES UN ATOMO DE OXIGENO O DE AZUFRE; Y ES UN ATOMO DE HIDROGENO, UN ALCOHILO INFERIOR, EN ESPECIAL UN METILO, EN POSICION 6 O UN GRUPO HIDROXILO EN POSICION 7; R ES UN ATOMO DE HIDROGENO, UN ALCOHILO INFERIOR, UN FENILO SUSTITUIDO O NO, UN BENCILO, EL GRUPO METOXIMETILO, EL GRUPO ACETILO, 2-ACETOXIETILO O EL GRUPO 2,2,2-TRIFLUOROETILO; Y R2 ES UN ATOMO DE HIDROGENO O UN ALCOHILO INFERIOR, EN ESPECIAL UN METILO. APLICACIONES DE ESTOS COMPUESTOS COMO MEDICAMENTOS ANTIALERGICOS.
ES90400827T 1989-03-30 1990-03-27 Pteridina-4 (3h)-onas, procedimientos de preparacion y medicamentos que los contienen. Expired - Lifetime ES2078324T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8904193A FR2645152B1 (fr) 1989-03-30 1989-03-30 3h-pteridinones-4, procedes de preparation et medicaments les contenant

Publications (1)

Publication Number Publication Date
ES2078324T3 true ES2078324T3 (es) 1995-12-16

Family

ID=9380213

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90400827T Expired - Lifetime ES2078324T3 (es) 1989-03-30 1990-03-27 Pteridina-4 (3h)-onas, procedimientos de preparacion y medicamentos que los contienen.

Country Status (30)

Country Link
US (1) US5167949A (es)
EP (1) EP0399856B1 (es)
JP (1) JPH0725761B2 (es)
AR (1) AR248278A1 (es)
AT (1) ATE126229T1 (es)
AU (1) AU630178B2 (es)
CA (1) CA2013324C (es)
CZ (1) CZ284679B6 (es)
DD (1) DD296927A5 (es)
DE (1) DE69021444T2 (es)
DK (1) DK0399856T3 (es)
ES (1) ES2078324T3 (es)
FR (1) FR2645152B1 (es)
GE (1) GEP19971023B (es)
GR (1) GR3017245T3 (es)
HR (1) HRP920759B1 (es)
HU (1) HU208826B (es)
IE (1) IE68689B1 (es)
IL (1) IL93914A (es)
LV (1) LV5821B4 (es)
MA (1) MA21786A1 (es)
NO (1) NO175100C (es)
NZ (1) NZ233130A (es)
OA (1) OA09441A (es)
PT (1) PT93600B (es)
RU (1) RU1836344C (es)
SI (1) SI9010633B (es)
TN (1) TNSN90040A1 (es)
YU (1) YU47346B (es)
ZA (1) ZA902397B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270465A (en) * 1989-03-30 1993-12-14 Lipha, Lyonnaise Industrille Pharmaceutique 4(3H)-pteridinone compounds
FR2772615B1 (fr) 1997-12-23 2002-06-14 Lipha Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
US6806272B2 (en) 2001-09-04 2004-10-19 Boehringer Ingelheim Pharma Kg Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
CN1551881A (zh) * 2001-09-04 2004-12-01 ���ָ��Ӣ��ķ�������Ϲ�˾ 新颖二氢喋啶酮,其制备方法及作为药物组合物的用途
FR2831789B1 (fr) 2001-11-07 2004-01-23 Oreal Procede et dispositif pour l'evaluation de la secheresse cutanee notamment
US6861422B2 (en) 2003-02-26 2005-03-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
DE102004029784A1 (de) 2004-06-21 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
DE102004033670A1 (de) * 2004-07-09 2006-02-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Pyridodihydropyrazinone, Verfahren zu Ihrer Herstellung und Ihre Verwendung als Arzneimittel
US20060035903A1 (en) * 2004-08-14 2006-02-16 Boehringer Ingelheim International Gmbh Storage stable perfusion solution for dihydropteridinones
US20060074088A1 (en) 2004-08-14 2006-04-06 Boehringer Ingelheim International Gmbh Dihydropteridinones for the treatment of cancer diseases
US7759485B2 (en) 2004-08-14 2010-07-20 Boehringer Ingelheim International Gmbh Process for the manufacture of dihydropteridinones
US20060058311A1 (en) 2004-08-14 2006-03-16 Boehringer Ingelheim International Gmbh Combinations for the treatment of diseases involving cell proliferation
US7728134B2 (en) 2004-08-14 2010-06-01 Boehringer Ingelheim International Gmbh Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
EP1632493A1 (de) 2004-08-25 2006-03-08 Boehringer Ingelheim Pharma GmbH & Co.KG Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
EP1630163A1 (de) 2004-08-25 2006-03-01 Boehringer Ingelheim Pharma GmbH & Co.KG Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102004058337A1 (de) * 2004-12-02 2006-06-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung von annelierten Piperazin-2-on Derivaten
US7439358B2 (en) 2006-02-08 2008-10-21 Boehringer Ingelheim International Gmbh Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
CA2680775A1 (en) * 2007-03-23 2008-10-02 F. Hoffmann-La Roche Ag Aza-pyridopyrimidinone derivatives
CA2695406A1 (en) 2007-08-03 2009-02-12 Boehringer Ingelheim International Gmbh Crystalline form of a dihydropteridione derivative
US8546566B2 (en) 2010-10-12 2013-10-01 Boehringer Ingelheim International Gmbh Process for manufacturing dihydropteridinones and intermediates thereof
US9358233B2 (en) 2010-11-29 2016-06-07 Boehringer Ingelheim International Gmbh Method for treating acute myeloid leukemia
US9370535B2 (en) 2011-05-17 2016-06-21 Boehringer Ingelheim International Gmbh Method for treatment of advanced solid tumors
WO2015011236A1 (en) 2013-07-26 2015-01-29 Boehringer Ingelheim International Gmbh Treatment of myelodysplastic syndrome
US9867831B2 (en) 2014-10-01 2018-01-16 Boehringer Ingelheim International Gmbh Combination treatment of acute myeloid leukemia and myelodysplastic syndrome

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3159628A (en) * 1962-05-28 1964-12-01 Smith Kline French Lab Pteridine-5-oxide derivatives
US3426019A (en) * 1962-06-29 1969-02-04 Smithkline Corp Derivatives of pteridine and a method for their preparation
SE307365B (es) * 1966-05-28 1969-01-07 Yoshitomi Pharmaceutical
US3732224A (en) * 1969-10-20 1973-05-08 Sherwin Williams Co Method of controlling plant growth and 3-substituted lumazines used in such method
US3819631A (en) * 1970-12-15 1974-06-25 May & Baker Ltd Azapurinones
US3859287A (en) * 1971-05-05 1975-01-07 Walter Wesley Parish Thiopteridines and process for producing same
DE2232098A1 (de) * 1972-06-30 1974-01-17 Boehringer Mannheim Gmbh 2-alkyl-4(3h)-pteridinone und verfahren zu ihrer herstellung
US4183934A (en) * 1978-10-16 1980-01-15 Abbott Laboratories 4-Hydroxy-7-(substituted)phenylpteridines
US4361700A (en) * 1980-05-20 1982-11-30 James S. Waldron Pyridopyrimidinone derivatives

Also Published As

Publication number Publication date
ATE126229T1 (de) 1995-08-15
DE69021444D1 (de) 1995-09-14
SI9010633B (sl) 1999-06-30
IE901157L (en) 1990-09-30
LV5821A4 (lv) 1997-04-20
HUT53646A (en) 1990-11-28
NO175100B (no) 1994-05-24
GR3017245T3 (en) 1995-11-30
NO901430D0 (no) 1990-03-29
HU901898D0 (en) 1990-08-28
CZ284679B6 (cs) 1999-02-17
HRP920759A2 (en) 1995-06-30
DD296927A5 (de) 1991-12-19
YU47346B (sh) 1995-01-31
PT93600B (pt) 1996-03-29
IL93914A0 (en) 1990-12-23
FR2645152B1 (fr) 1991-05-31
RU1836344C (ru) 1993-08-23
GEP19971023B (en) 1997-06-13
HU208826B (en) 1994-01-28
EP0399856B1 (fr) 1995-08-09
SI9010633A (en) 1997-02-28
JPH02304089A (ja) 1990-12-17
NO901430L (no) 1990-10-01
NZ233130A (en) 1992-01-29
DE69021444T2 (de) 1996-03-14
MA21786A1 (fr) 1990-10-01
IL93914A (en) 1994-02-27
DK0399856T3 (da) 1995-09-18
EP0399856A1 (fr) 1990-11-28
OA09441A (fr) 1992-10-15
LV5821B4 (lv) 1997-10-20
CA2013324A1 (fr) 1990-09-30
HRP920759B1 (en) 1998-08-31
AU5221890A (en) 1990-10-04
ZA902397B (en) 1991-01-30
IE68689B1 (en) 1996-07-10
YU63390A (en) 1991-10-31
CA2013324C (fr) 2001-08-21
PT93600A (pt) 1990-11-20
CZ152090A3 (cs) 1998-11-11
NO175100C (no) 1994-08-31
FR2645152A1 (fr) 1990-10-05
AU630178B2 (en) 1992-10-22
AR248278A1 (es) 1995-07-12
TNSN90040A1 (fr) 1991-03-05
JPH0725761B2 (ja) 1995-03-22
US5167949A (en) 1992-12-01

Similar Documents

Publication Publication Date Title
ES2078324T3 (es) Pteridina-4 (3h)-onas, procedimientos de preparacion y medicamentos que los contienen.
DE3853477D1 (de) Makrozyklische verbindungen.
ATE214393T1 (de) Bis(3,4-dialkylbenzyliden)sorbitolacetale und diese enthaltende zusammensetzungen
DK139287A (da) Tertiaere hydroxyalkylxanthiner, deres fremstilling og anvendelse som laegemidler
ES2052881T3 (es) Agentes reductores de la presion sanguinea.
SE7602235L (sv) Sett att framstella nya 6,7-bensomorfanderivat
DK0421561T3 (da) 24-homo-vitamin-D-derivater, fremgangsmåder til fremstilling heraf, farmaceutiske præparater indeholdende disse derivater samt deres anvendelse som lægemiddel
DK0482071T3 (da) Nye antivirale midler
ATE154805T1 (de) Oberflächenaktive, von sulfobernsteinsäureestern abgeleitete verbindungen
DE3681109D1 (de) Stickstoffhaltige heterozyklische verbindungen.
ATE57528T1 (de) Aromatische verbindungen.
ES2074828T3 (es) Copoliester degradable de 4-hidroxi-prolina y composicion farmaceutica que lo contiene.
ES2062071T3 (es) Procedimiento de preparacion de ((diarilmetoxi) alcoil)-1 pirrolidinas y piperidinas y medicamentos que las contienen.
ES2038776T3 (es) Procedimiento de preparacion de derivados de la oxima del 1,2,5,6-tetrahidropiridin-3-carboxaldehido.
DE69023939T2 (de) Förderung der Osteogenese durch Verwendung von Vitamin D-Derivaten.
SE7909751L (sv) 4,1-bensoxazepiner och tia-analoger derav
KR880009568A (ko) 안정화 고형 조성물
FR2378518A1 (fr) Nouveaux medicaments a base de derives de tetrahydrodibenzopyranne
FI832007A0 (fi) En ny mikroorganismstam chromobacterium violaceum, medelst denna stam framstaellda farmaceutiskt aktiva foereningar, ett foerfarande foer framstaellning av foereningarna och anvaendning av dessa foereningar som laekemedel
ES2138434T3 (es) Compuesto fluoropropeno, un insecticida que lo contiene, y un compuesto intermediario para su preparacion.
ATE91033T1 (de) Photochromische zusammensetzung und diese zusammensetzung enthaltende gegenstaende.
NO903291D0 (no) Renin-hemmende aminooligohydroksy-derivater.
SE7708452L (sv) Komposition innehallande en antrakinonforening
ATE36520T1 (de) Polyprenylverbindung, ihre herstellung und pharmazeutische verwendung.
FR2381008A1 (fr) Nouveaux patchoulols hydroxyles

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 399856

Country of ref document: ES